Table 1 .
Exclusion Criteria and the Number of Subjects Excludeda
| Exclusion Criteria | Children Aged 1-19 Years | Adults Aged 20-79 Years | ||
|---|---|---|---|---|
| Number Excluded | Total Excluded | Number Excluded | Total Excluded | |
| None or incomplete CBC | 5,981 | 5,981 | 3,223 | 3,223 |
| Pregnancy | 181 | 6,147 | 1,351 | 4,422 |
| Lactation | 35 | 6,180 | 252 | 4,645 |
| Anemia | 433 | 6,526 | 1,305 | 5,656 |
| Coronary heart failure | 0 | 6,526 | 947 | 6,383 |
| Coronary heart disease | 0 | 6,526 | 1,198 | 7,097 |
| Angina | 0 | 6,526 | 902 | 7,437 |
| Acute myocardial infarction | 0 | 6,526 | 1,272 | 7,795 |
| Cancer | 0 | 6,526 | 2,637 | 9,641 |
| Gout | 0 | 6,526 | 669 | 10,005 |
| Emphysema | 0 | 6,526 | 651 | 10,269 |
| Liver condition | 0 | 6,526 | 1,200 | 11,034 |
| Celiac disease | 7 | 6,531 | 27 | 11,052 |
| Stroke | 0 | 6,531 | 1,098 | 11,460 |
| Thyroid condition | 0 | 6,531 | 2,561 | 12,897 |
| Hepatitis C | 8 | 6,539 | 641 | 13,198 |
| HIV | 3 | 6,542 | 116 | 13,269 |
| Daily aspirin use | 0 | 6,542 | 1,754 | 13,987 |
| Hematologic prescription drug useb | 0 | 6,542 | 21 | 13,989 |
| Donated blood | 180 | 6,714 | 573 | 14,425 |
| Total before exclusions | 30,545 | 34,922 | ||
| Total excluded | 6,714 | 14,425 | ||
| Total after exclusions | 23,831 | 20,497 | ||
aData from National Health and Nutrition Examination Survey 1999 to 2012.
bIncluding erythropoiesis stimulating agents (erythropoietin, epoetin alfa, darbepoetin alfa) and colony stimulating agents (filgrastim).